Voltage-gated sodium channel Nav1.7 promotes gastric cancer progression through MACC1-mediated upregulation of NHE1

International Journal of Cancer

Volumn 139, Issue 11, 2016, Pages 2553-2569

  Xia, Jianling ^a   Huang, Na ^a   Huang, Hongxiang ^a   Sun, Li ^a   Dong, Shaoting ^a   Su, Jinyu ^a   Zhang, Jingwen ^a   Wang, Lin ^a   Lin, Li ^a   Shi, Min ^a   Bin, Jianping ^a   Liao, Yulin ^a   Li, Nailin ^b   Liao, Wangjun ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Gastric cancer; MACC1; Nav1.7; NHE1; Tumor progression

Indexed keywords

METASTASIS ASSOCIATED IN COLON CANCER 1 PROTEIN; ONCOPROTEIN; PROTEIN C JUN; SCATTER FACTOR; SODIUM CHANNEL NAV1.7; SODIUM PROTON EXCHANGE PROTEIN 1; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BGC 823 CELL LINE; CANCER CELL CULTURE; CANCER CELL LINE; CANCER GROWTH; CANCER TISSUE; CELL INVASION; CELL PH; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; ELECTROPHYSIOLOGY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MKN 28 CELL LINE; MOUSE; MTT ASSAY; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SCN9A GENE; SODIUM CURRENT; STOMACH CANCER; TUMOR XENOGRAFT; TUNEL ASSAY; UPREGULATION; WESTERN BLOTTING;

EID: 84987949068     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.30381     Document Type: Article

References (50)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10–29.
2. Pedersen SF, Stock C. Ion channels and transporters in cancer: pathophysiology, regulation, and clinical potential. Cancer Res 2013;73:1658–61.
3. Lee J-H, Park C-K, Chen G, et al. A Monoclonal antibody that targets a NaV1.7 channel voltage sensor for pain and itch relief. Cell 2014;157:1393–404.
4. Lorincz A, Nusser Z. Molecular identity of dendritic voltage-gated sodium channels. Science 2010;328:906–09.
5. Klausen TK, Preisler S, Pedersen SF, et al. Monovalent ions control proliferation of Ehrlich Lettre ascites cells. Am J Physiol Cell Physiol 2010;299:C714–25.
6. Roger S, Gillet L, Le Guennec JY, et al. Voltage-gated sodium channels and cancer: is excitability their primary role? Front Pharmacol 2015;6:152
7. Besson P, Driffort V, Bon É, et al. How do voltage-gated sodium channels enhance migration and invasiveness in cancer cells? Biochim Biophys Acta 2015;1848:2493–501.
8. Patel F, Brackenbury W. Dual roles of voltage-gated sodium channels in development and cancer. Int J Dev Biol 2015;59:357–66.
9. Gillet L, Roger S, Besson P, et al. Voltage-gated sodium channel activity promotes cysteine cathepsin-dependent invasiveness and colony growth of human cancer cells. J Biol Chem 2009;284:8680–91.
10. House CD, Vaske CJ, Schwartz AM, et al. Voltage-gated Na+ channel SCN5A is a key regulator of a gene transcriptional network that controls colon cancer invasion. Cancer Res 2010;70:6957–67.
11. Koliakos G, Paletas K, Kaloyianni M. NHE-1: A molecular target for signalling and cell matrix interactions. Connect Tissue Res 2008;49:157–61.
12. Barar J, Omidi Y. Dysregulated pH in tumor microenvironment checkmates cancer therapy. Bioimpacts 2013;3:149–62.
13. Pedersen SF. The Na+/H+ exchanger NHE1 in stress-induced signal transduction: implications for cell proliferation and cell death. Pflugers Arch 2006;452:249–59.
14. Webb BA, Chimenti M, Jacobson MP, et al. Dysregulated pH: a perfect storm for cancer progression. Nature Rev Cancer 2011;11:671–7.
15. Cong D, Zhu W, Shi Y, et al. Upregulation of NHE1 protein expression enables glioblastoma cells to escape TMZ-mediated toxicity via increased H(+) extrusion, cell migration and survival. Carcinogenesis 2014;35:2014–24.
16. Kumar AP, Quake AL, Chang MK, et al. Repression of NHE1 expression by PPARgamma activation is a potential new approach for specific inhibition of the growth of tumor cells in vitro and in vivo. Cancer Res 2009;69:8636–44.
17. Yang X, Wang D, Dong W, et al. Expression and modulation of Na(+)/H(+) exchanger 1 gene in hepatocellular carcinoma: A potential therapeutic target. J Gastroenterol Hepatol 2011;26:364–70.
18. Loo SY, Chang MK, Chua CS, et al. NHE-1: a promising target for novel anti-cancer therapeutics. Curr Pharm Des 2012;18:1372–82.
19. Hossain MM, Sonsalla PK, Richardson JR. Coordinated role of voltage-gated sodium channels and the Na+/H+ exchanger in sustaining microglial activation during inflammation. Toxicol Appl Pharmacol 2013;273:355–64.
20. Wang L, Wu Y, Lin L, et al. Metastasis-associated in colon cancer-1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion. Int J Cancer 2013;133:1419–30.
21. Sun L, Duan J, Jiang Y, et al. Metastasis-associated in colon cancer-1 upregulates vascular endothelial growth factor-C/D to promote lymphangiogenesis in human gastric cancer. Cancer Lett 2015;357:242–53.
22. Wang L, Lin L, Chen X, et al. Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2. Oncotarget 2015;6:11492–506.
23. Lin L, Huang H, Liao W, et al. MACC1 supports human gastric cancer growth under metabolic stress by enhancing the Warburg effect. Oncogene 2015;34:2700–10.
24. Chen M, Zou X, Luo H, et al. Effects and mechanisms of proton pump inhibitors as a novel chemosensitizer on human gastric adenocarcinoma (SGC7901) cells. Cell Biol Int 2009;33:1008–19.
25. Lu Y, Pang T, Wang J, et al. Down-regulation of P-glycoprotein expression by sustained intracellular acidification in K562/Dox cells. Biochem Biophys Res Commun 2008;377:441–6.
26. Jin W, Lu Y, Li Q, et al. Down-regulation of the P-glycoprotein relevant for multidrug resistance by intracellular acidification through the crosstalk of MAPK signaling pathways. Int J Biochem Cell Biol 2014;54:111–21.
27. Kollipara PS, Jeong HS, Han SB, et al. (E)−2,4-bis(p-hydroxyphenyl)−2-butenal has an antiproliferative effect on NSCLC cells induced by p38 MAPK-mediated suppression of NF-kappaB and up-regulation of TNFRSF10B (DR5). Br J Pharmacol 2013;168:1471–84.
28. Stein U, Walther W, Arlt F, et al. MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nature Med 2009;15:59–67.
29. Chen HT, Tsou HK, Chang CH, et al. Hepatocyte growth factor increases osteopontin expression in human osteoblasts through PI3K, Akt, c-Src, and AP-1 signaling pathway. PloS One 2012;7:e38378.
30. Madeo A, Vinciguerra M, Lappano R, et al. c-Jun activation is required for 4-hydroxytamoxifen-induced cell death in breast cancer cells. Oncogene 2010;29:978–91.
31. Dikshit B, Irshad K, Madan E, et al. FAT1 acts as an upstream regulator of oncogenic and inflammatory pathways, via PDCD4, in glioma cells. Oncogene 2013;32:3798–808.
32. Zhang Q, Yang Z, Jia ZQ, et al. ISL-1 is overexpressed in non-Hodgkin lymphoma and promotes lymphoma cell proliferation by forming a p-STAT3/p-c-Jun/ISL-1 complex. Mol Cancer 2014;13:181
33. Yang M, Brackenbury WJ. Membrane potential and cancer progression. Front Physiol 2013;4:185
34. Roger S, Rollin J, Barascu A, et al. Voltage-gated sodium channels potentiate the invasive capacities of human non-small-cell lung cancer cell lines. Int J Biochem Cell Biol 2007;39:774–86.
35. +-channel Nav1.7 is necessary for EGF-mediated invasion in human non-small cell lung cancer cells. J Cell Sci 2013;126:4939–49.
36. Driffort V, Gillet L, Bon E, et al. Ranolazine inhibits NaV1.5-mediated breast cancer cell invasiveness and lung colonization. Mol Cancer 2014;13:264
37. Brisson L, Gillet L, Calaghan S, et al. Na(V)1.5 enhances breast cancer cell invasiveness by increasing NHE1-dependent H(+) efflux in caveolae. Oncogene 2011;30:2070–6.
38. Brisson L, Driffort V, Benoist L, et al. NaV1.5 Na+ channels allosterically regulate the NHE-1 exchanger and promote the activity of breast cancer cell invadopodia. J Cell Sci 2013;126:4835–42.
39. Onkal R, Djamgoz MB. Molecular pharmacology of voltage-gated sodium channel expression in metastatic disease: clinical potential of neonatal Nav1.5 in breast cancer. Eur J Pharmacol 2009;625:206–19.
40. House CD, Wang BD, Ceniccola K, et al. Voltage-gated Na+ channel activity increases colon cancer transcriptional activity and invasion via persistent MAPK signaling. Sci Rep 2015;5:11541
41. Hernandez-Plata E, Ortiz CS, Marquina-Castillo B, et al. Overexpression of NaV 1.6 channels is associated with the invasion capacity of human cervical cancer. Int J Cancer 2012;130:2013–23.
42. Xing D, Wang J, Ou S, et al. Expression of neonatal Nav1.5 in human brain astrocytoma and its effect on proliferation, invasion and apoptosis of astrocytoma cells. Oncol Rep 2014;31:2692–700.
43. Anderson JD, Hansen TP, Lenkowski PW, et al. Voltage-gated sodium channel blockers as cytostatic inhibitors. Mol Cancer Ther 2003;2:1149–54.
44. Wannous R, Bon E, Gillet L, et al. Suppression of PPARβ, and DHA treatment, inhibit NaV1.5 and NHE-1 pro-invasive activities. Pflugers Arch 2015;46:1249–59.
45. Sever R, Brugge JS. Signal transduction in cancer. Cold Spring Harb Perspect Med 2015;5:a006098
46. Wagner EF, Nebreda AR. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 2009;9:537–49.
47. Dai T, Zhang D, Cai M, et al. Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma cell aggressiveness by activating the NF-κB pathway. J Pathol 2015;235:490–501.
48. You H, Ding W, Dang H, et al. c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma. Hepatology 2011;54:879–89.
49. Kim YJ, Yoon SY, Kim JT, et al. NDRG2 suppresses cell proliferation through down-regulation of AP-1 activity in human colon carcinoma cells. Int J Cancer 2009;124:7–15.
50. Sun Y, Tang S, Jin X, et al. Opposite effects of JNK and p38 MAPK signaling pathways on furazolidone-stimulated S phase cell cycle arrest of human hepatoblastoma cell line. Mutat Res 2013;755:24–9.